4//SEC Filing
Cullen Michael T. 4
Accession 0001437749-21-013591
CIK 0001029125other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 8:48 PM ET
Size
7.6 KB
Accession
0001437749-21-013591
Insider Transaction Report
Form 4
Cullen Michael T.
Director
Transactions
- Award
Common Stock
2021-05-25+4,316→ 216,811 total - Award
Stock Option (right to buy)
2021-05-25+12,368→ 12,368 totalExercise: $4.17Exp: 2031-05-25→ Common Stock (12,368 underlying)
Holdings
- 204,576(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes 4,500 shares previously reported as disposed of through gift transactions that were not completed.
- [F2]Scheduled to vest and become exercisable in four equal increments on August 25, 2021, November 24, 2021, February 25, 2022 and the earlier of May 31, 2022 and the day before the company's annual meeting of stockholders to be held in 2022.
Documents
Issuer
Panbela Therapeutics, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001652996
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 8:48 PM ET
- Size
- 7.6 KB